Abbott Laboratories (XSWX:ABT) Construction In Progress : CHF0 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Construction In Progress?

Abbott Laboratories's quarterly construction in progress increased from Sep. 2023 (CHF0 Mil) to Dec. 2023 (CHF1,785 Mil) but then declined from Dec. 2023 (CHF1,785 Mil) to Mar. 2024 (CHF0 Mil).

Abbott Laboratories's annual construction in progress increased from Dec. 2021 (CHF1,201 Mil) to Dec. 2022 (CHF1,382 Mil) and increased from Dec. 2022 (CHF1,382 Mil) to Dec. 2023 (CHF1,785 Mil).

Abbott Laboratories Construction In Progress Historical Data

The historical data trend for Abbott Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Construction In Progress Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,090.69

1,205.56

1,200.98

1,382.49

1,784.95

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															-	-	-	1,784.95	-

Abbott Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Abbott Laboratories (XSWX:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.